Cleaveland JS - Search Results

1

Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail.

Leung HT, Bradshaw J, Cleaveland JS, Linsley PS. Leung HT, et al. Among authors: cleaveland js. J Biol Chem. 1995 Oct 20;270(42):25107-14. doi: 10.1074/jbc.270.42.25107. J Biol Chem. 1995. PMID: 7559643 Free article.

2

Differential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequences.

Nadler SG, Tritschler D, Haffar OK, Blake J, Bruce AG, Cleaveland JS. Nadler SG, et al. Among authors: cleaveland js. J Biol Chem. 1997 Feb 14;272(7):4310-5. doi: 10.1074/jbc.272.7.4310. J Biol Chem. 1997. PMID: 9020149 Free article.

3

Determination of immunoreactivity of doxorubicin antibody immunoconjugates by a Le(y) competitive RIA.

Zhao H, Willner D, Cleaveland JS, Braslawsky GR, Brown JP. Zhao H, et al. Among authors: cleaveland js. Bioconjug Chem. 1992 Nov-Dec;3(6):549-53. doi: 10.1021/bc00018a014. Bioconjug Chem. 1992. PMID: 1361153

4

Transport of the immunosuppressant 15-deoxyspergualin in human peripheral blood lymphocytes.

Cleaveland JS, Nadler SG. Cleaveland JS, et al. Biochem Biophys Res Commun. 1993 Aug 31;195(1):455-61. doi: 10.1006/bbrc.1993.2065. Biochem Biophys Res Commun. 1993. PMID: 8363621

5

Effect of interferon-gamma on antigen processing in human monocytes.

Nadler SG, Rankin BM, Moran-Davis P, Cleaveland JS, Kiener PA. Nadler SG, et al. Among authors: cleaveland js. Eur J Immunol. 1994 Dec;24(12):3124-30. doi: 10.1002/eji.1830241232. Eur J Immunol. 1994. PMID: 7805741

6

Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin.

Nadler SG, Dischino DD, Malacko AR, Cleaveland JS, Fujihara SM, Marquardt H. Nadler SG, et al. Among authors: cleaveland js. Biochem Biophys Res Commun. 1998 Dec 9;253(1):176-80. doi: 10.1006/bbrc.1998.9775. Biochem Biophys Res Commun. 1998. PMID: 9875240

7

Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin.

Nadler SG, Eversole AC, Tepper MA, Cleaveland JS. Nadler SG, et al. Among authors: cleaveland js. Ther Drug Monit. 1995 Dec;17(6):700-3. doi: 10.1097/00007691-199512000-00026. Ther Drug Monit. 1995. PMID: 8588244

8

Studies on the interaction of the immunosuppressant 15-deoxyspergualin with heat shock proteins.

Nadler SG, Cleaveland J, Tepper MA, Walsh C, Nadeau K. Nadler SG, et al. Ann N Y Acad Sci. 1993 Nov 30;696:412-4. doi: 10.1111/j.1749-6632.1993.tb17181.x. Ann N Y Acad Sci. 1993. PMID: 8109853 No abstract available.

9

An intracellular targeted NLS peptide inhibitor of karyopherin alpha:NF-kappa B interactions.

Cunningham MD, Cleaveland J, Nadler SG. Cunningham MD, et al. Biochem Biophys Res Commun. 2003 Jan 10;300(2):403-7. doi: 10.1016/s0006-291x(02)02863-2. Biochem Biophys Res Commun. 2003. PMID: 12504098

10

A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease.

Fujihara SM, Cleaveland JS, Grosmaire LS, Berry KK, Kennedy KA, Blake JJ, Loy J, Rankin BM, Ledbetter JA, Nadler SG. Fujihara SM, et al. Among authors: cleaveland js. J Immunol. 2000 Jul 15;165(2):1004-12. doi: 10.4049/jimmunol.165.2.1004. J Immunol. 2000. PMID: 10878377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters